About us

Planta was founded in 1994 by three dynamic biotechnologists whose aim was to put their ideas and visions into practice. Today Planta is an innovative drug development company which uses nature itself as its role model whilst maintaining EMA and FDA guidelines as standard instructions.

Our Philosophy and Vision

Nature is full of hidden treasures. We work on drawing structures, mechanisms and pathways from these treasures, as a base for developing new active substances and treatment strategies. The organization of our R&D complies to the guidelines of EMA and FDA.

Team

Our staff members’ academic backgrounds lie in the fields of biochemistry, biology, pharmacology and toxicology. Our permanent key personal consists of six co-workers – a small group which allows for a compact and familiar atmosphere. Flexibility is our strength and is a great asset to our customers and cooperation partners.

MANAGEMENT
_

Georg Jessner, MSc

Founder and shareholder
g.jessner

planta

at

Selective studies of Food- and Biotechnology and Nutrition at BOKU-University of Natural Resources and Life Sciences, Vienna, and Vienna University of Technology. Non-permanent staff at the Institute of Chemistry at the University of Natural Resources and Life Sciences, Vienna. 1995–1996 Employee at Public Office and Research Centre for Agriculture, and Institute for Beverage Analysis (particularly official wine analysis). Since 1996 CEO of PLANTA Natural Products GmbH.

Main tasks and areas of competence: finance, production, toxicology

Andreas Kubin, PhD

Founder and shareholder
a.kubin

planta

at

Completed the study of Biotechnology at BOKU-University of Natural Resources and Life Sciences, Vienna. 17 years work experience in research and drug development. Since 2002 has held the position of CEO of PLANTA Natural Products GmbH. Previously, (1993-2004), was employed at the Ludwig Boltzmann Institute for Clinical Oncology and Photodynamic Therapy, Vienna Austria. Between 2011– 2015 CEO of INOXIA Lifesciences GmbH, a research company specialised in drug development.

Main tasks and areas of competence: finance, drug development and formulation, patenting, publication